학술논문
Double-Blind, Placebo Controlled, Randomized, Multicenter, Phase II Study to Assess the Efficacy of the High Affinity CXCR4 Inhibitor BL-8040 As Addition to Consolidation Therapy in AML By the SAL and OSHO Leukemia Study Groups
Document Type
Abstract
Author
Jaramillo Segura, Sonia ; Wass, Maxi ; Schaffrath, Judith ; Rieger, Kathrin ; Nogai, Axel ; Haenel, Mathias ; Herbst, Regina ; Stoelzel, Friedrich; Röllig, Christoph ; Jost, Edgar ; Schlenk, Richard F.; Noppeney, Richard ; Brandts, Christian H. ; Krug, Utz; Goetze, Katharina S.; Buske, Sebastian ; Florschütz, Axel ; Schubert, Jörg ; Opitz, Bernhard ; Mohren, Martin ; Eßeling, Eva ; von Witzendorff, Stephan ; Subklewe, Marion; Kaufmann, Martin; Frickhofen, Norbert ; Scholz, Christian W; Schäfer-Eckart, Kerstin ; Kunzmann, Volker ; Schmidt-Hieber, Martin ; Sayer, Herbert G.; Rank, Andreas ; Hemmati, Philipp ; Schueler, Frank; Kowoll, Simone ; Scheller, Marina ; Steighardt, Jörg ; Edemir, Bayram ; Mueller, Lutz Peter ; Gliko-Kabir, Irit ; Ludwig-Kraus, Beatrice ; Edemir, Sabine ; Sorani, Ella ; Binder, Mascha ; Vainstein, Abi ; Kadosh, Shaul ; Gromann, Cora ; Wienke, Andreas ; Baldus, Claudia D. ; Platzbecker, Uwe; Serve, Hubert; Bornhaeuser, Martin; Junghanss, Christian ; Mueller-Tidow, Carsten
Source
In Blood 15 November 2022 140 Supplement 1:3338-3340
Subject
Language
ISSN
0006-4971